Explore the catalog ✦Browse by compound and format ✦Scientific reference information ✦Lot records when available ✦
Shadow Labs research vial of retatrutide 20 mg lyophilized peptide, black label, marked research use only.
Peptides · Research reference

Retatrutide 20mg

Research reference entry. Listed as available in the supplied stock list. Not offered for purchase.

A$225In stock
1
Pay with Bitcoin or Litecoin. Stock is held while your invoice is open.

Specifications

Key actives20 mg
FormatResearch vial / kit
SKUSL-R013
StorageLyophilized solid in a sealed vial. Store at [STORAGE TEMPERATURE].
TestingListed purity [PURITY %]. Testing laboratory: [TESTING LAB]. Certificate panel: [COA PANEL].
Lab reportsAll lots →

No published lot documentation is available for this entry.

For research use only. Not for human consumption. This page is not a use guide, a medical claim, or an offer to purchase.

Scientific reference

About Retatrutide 20 mg research peptide

Overview

Retatrutide 20 mg, SL-R013, is a sealed lyophilized research vial. The labeled mass is nominal and is not a use amount.

Retatrutide (LY3437943) is a 39-residue peptide with nonstandard residues, including a lipid side chain. The mass below is the free peptide from the GSRS chemical definition, not the sodium salt.

Chemical identity

The USAN statement lists 2-methylalanine at positions 2 and 20, 2-methylleucine at position 13, a substituted lysine at position 17, and a C-terminal serinamide. The unmodified 39-letter string leaves those groups out, so it is not printed. The GSRS chemical definition of the parent substance (UNII NOP2Y096GV, charge 0) gives formula C221H342N46O68 and molecular weight 4731.36. That is the free peptide. Retatrutide sodium is a separate UNII and is not the form cited here.

CodeLY3437943
CAS2381089-83-2
Length39 residues, with the modifications named by USAN
Form citedFree peptide (GSRS chemical definition, charge 0), not the sodium salt
Molecular formulaC221H342N46O68
Molecular weight4731.36 (GSRS chemical definition of the free peptide)

Form and appearance

Sealed research vial of lyophilized solid. Listed purity [PURITY %].

Storage and handling

Leave the seal intact. Store at [STORAGE TEMPERATURE]. Published certificates list [COA PANEL] from [TESTING LAB].

Published research

Jastreboff and colleagues reported a phase 2 study of retatrutide as an agonist at the GIP, GLP-1, and glucagon receptors (N Engl J Med. 2023;389:514-526). The primary endpoint was percent change in body mass at 24 weeks.

That trial does not describe this vial. The catalog mass is not a study amount, and no outcome is claimed for the listing.

Research and regulatory status

Research use only. Not for human consumption. The published lot certificate is the batch record for this entry.

Frequently asked questions

What does 20 mg mean?

It is the nominal mass on this catalog entry. It is not a use amount, and it is not the study amount from any paper.

Which molecular weight is listed?

4731.36, from the GSRS chemical definition of the free peptide (charge 0). The sodium salt is a different record and is not the mass used here.

Does the phase 2 paper describe this product?

No. It describes the named compound in a clinical study. It is not a certificate for this vial.

What purity is listed?

Listed purity is [PURITY %]. Certificates name [TESTING LAB] and the panel [COA PANEL].

How should this vial be stored?

Store at [STORAGE TEMPERATURE] and leave the seal intact.

For research use only. Not for human consumption. This page is not a use guide, a medical claim, or an offer to purchase.

Related research

Explore related entries